Question 1

How many employees does Prelude Therapeutics (PRLD) have?

Accepted Answer

Prelude Therapeutics (PRLD) currently has 68 employees as of the most recent reporting period. This data is sourced from official SEC filings.

Question 2

What is Prelude Therapeutics's employee count history?

Accepted Answer

Prelude Therapeutics (PRLD) has employee count data available from undefined to undefined. The company's workforce has varied over this period, with the most recent count being 68.

Question 3

Has Prelude Therapeutics's employee count increased or decreased?

Accepted Answer

Prelude Therapeutics (PRLD) decreased its employee count by 48 employees (-41.38%) from NaN to undefined.

Question 4

Where does Prelude Therapeutics's employee count data come from?

Accepted Answer

Prelude Therapeutics (PRLD) employee count data is sourced from official SEC filings, including annual reports (10-K) and quarterly reports (10-Q). This data is reported by the company itself and is publicly available through the U.S. Securities and Exchange Commission.

Question 5

What is Prelude Therapeutics's revenue per employee?

Accepted Answer

Revenue per employee metrics for Prelude Therapeutics (PRLD) are calculated by dividing the company's annual revenue by its total employee count. This metric helps assess operational efficiency and can be viewed in our detailed employee data visualization.

Prelude Therapeutics PRLD Employee Data

Current & Historical Employee Count

Prelude Therapeutics (PRLD) annual worldwide employee count from 2021 to 2026, with year-over-year trends and revenue-per-employee where fiscal data allows.

Company Executives

Current executive leadership team at Prelude Therapeutics (PRLD)

Insider Trade History

Recent and historical insider trading activity at Prelude Therapeutics (PRLD)

Boost your savings and earn 3.95% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.

Compete

Explore

Research

Financhle